ELEn-Pei Lee

En-Pei Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


En-Pei Lee has a total of 94 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Highly neutralizing anti–IFN-ω autoantibodies underlie severe pediatric adenovirus infection

    by Chen-Xuan Kang, Jing-Ya Ding, Yu-Fang Lo, Tsai-Yi Wu, Han-Po Shih, Jhan-Jie Peng, Kung-Wei Lin, You-Ning Lin, Chia-Chi Lo, Shao-Hsuan Hsia, et al.

    Neutralizing autoantibodies (auto-Abs) against type I IFNs (IFN-α and IFN-ω) have emerged as major acquired risk factors for severe viral infections. Human adenovirus (HAdV) is highly prevalent in children and can cause severe pneumonia, but the host determinants of disease severity remain poorly understood. We describe here a 5-year-old child with life-threatening HAdV-B7 pneumonia requiring intensive care who carried high-titer anti–IFN-ω auto-Abs of the IgG1 and IgG3 subclasses. Peripheral blood mononuclear cells produced normal amounts of IFN-α and IFN-ω ex vivo; however, IFN-ω was undetectable in the plasma during acute illness. Functional assays demonstrated that the patient’s plasma strongly neutralized IFN-ω, abolishing its antiviral signaling and protective effects, resulting in high levels of adenovirus replication and virus-induced cytotoxicity. These findings implicate anti–IFN-ω auto-Abs in severe adenoviral infection and support immunological screening of pediatric patients with unexplained severe viral pneumonia, which may guide targeted management.

  • Open Access

    Application of procalcitonin in pediatric emergency and critical care settings

    by Han-Ping Wu, En-Pei Lee, Jainn-Jim Lin, Jong-Hau Hsu, Mei-Jy Jeng, En-Ting Wu, Ting-Yuan Hsu, Po-Yu Wang, Chien-Yi Wu, Po-Ming Wu, et al.

  • Open Access

    Effect of a liquid crystal vein locator on intravenous catheterization in young children: a randomized trial

    by Han-Ping Wu, Bei-Cyuan Guo, Yu-Jun Chang, Chun-Yu Chen, Sheng-Ling Jan, En-Pei Lee

    Background and importance: Peripheral intravenous catheterization (PIVC) in young children is notoriously challenging because of factors like poor patient cooperation and small vessel diameter. Repeated attempts cause distress and delay critical emergency treatment. Objective(s): This study aimed to evaluate the effect of a novel liquid crystal display-based near-infrared vein locator on PIVC performance in children aged under 3 years. Design: This is a prospective, randomized controlled trial. Settings and participants: A total of 105 children aged 0–3 years requiring PIVC were enrolled in a pediatric emergency department. Intervention: Participants were randomly assigned to undergo PIVC using either a liquid crystal vein locator (study group, n = 50) or the traditional landmark-based method (control group, n = 55). Outcome measures and analysis: The primary endpoint was the first-attempt success rate. Secondary endpoints included the number of puncture attempts, vein localization time, and total insertion time. Multivariable logistic and Poisson regression models were used to adjust for covariates, such as vein difficulty and patient demographics. Analyses included effect sizes with 95% confidence intervals (CIs). Main results: The baseline characteristics of both groups were comparable. The first-attempt success rate was significantly higher in the study group compared to the control group (86.0% vs. 54.5%; absolute difference: 31.5%; 95% CI: 15.2–47.8%). The study group also demonstrated a significantly shorter median vein localization time (16.5 vs. 60.0 s) and median total insertion time (40.0 vs. 185.0 s). In addition, the device significantly reduced the median number of puncture attempts (adjusted rate ratio: 0.77; 95% CI: 0.66–0.90). Multivariable analysis revealed that device assistance was an independent predictor of first-attempt success (adjusted odds ratio: 3.35; 95% CI: 1.13–9.95). Conclusion: In this study, the use of a liquid crystal vein locator was associated with a significantly higher first-attempt success rate, fewer puncture attempts, and reduced procedural times for PIVC in young children.

  • Tocilizumab Therapy in Gram-Positive and Gram-Negative Pediatric Septic Shock: A Comparative Pilot Study

    by Kiew-Kii Lau, Jainn-Jim Lin, Oi-Wa Chan, Shao-Hsuan Hsia, En-Pei Lee

    Background: Elevated interleukin-6 (IL-6) is strongly associated with disease severity and mortality in pediatric septic shock. This study investigated whether adjunctive tocilizumab, a humanized anti-IL-6 receptor antibody, improves clinical outcomes in children with Gram-positive bacteria (GPB) and Gram-negative bacteria (GNB) septic shock. Methods: This retrospective cohort study included 58 children with septic shock (32 receiving adjunctive tocilizumab and 26 historical controls). We evaluated mortality rates, shock duration, and intensive care unit (ICU) length of stay, with further stratification by pathogen type. Results: Baseline demographics and initial disease severity were comparable between the groups. Tocilizumab administration was associated with a significantly shorter median shock duration (84 vs. 240 hours; p < 0.001), reduced ICU stay (6 vs. 14 days; p = 0.002), and lower mortality (18.7% vs. 46.1%; p = 0.02) compared to controls. In subgroup analyses, tocilizumab significantly decreased mortality in GNB sepsis (23.8% vs. 56.2%; p = 0.04) and improved 28-day survival (log-rank p = 0.023). Notably, although tocilizumab-treated GNB patients had markedly higher initial IL-6 levels (median 7531 vs. 294 pg/mL; p = 0.014) and PRISM III scores than GPB patients, post-treatment mortality did not differ significantly between these cohorts (23.8% vs. 9.0%; p = 0.31). Conclusions: Adjunctive tocilizumab is associated with improved survival and shortened shock duration in pediatric septic shock. Targeted IL-6 blockade effectively neutralizes the hyperinflammatory surge, narrowing the clinical outcome gap typically driven by severe GNB infections.

  • Open Access

    Early parameter to detect the resolution of pediatric diabetic ketoacidosis

    by Yi-Hsuan Liu, Ya-Ting Su, Jainn-Jim Lin, Oi-Wa Chan, Chen-Wei Yen, En-Pei Lee

    Objective: The present study aimed to analyze the incidence of hyperchloremia and compare the time to reach DKA resolution with different parameters.Methods: A chart review of patients diagnosed with DKA and aged 3 >15 mmol/L prior.Conclusions: Hyperchloremic metabolic acidosis (HMA) was a common entity in pediatric DKA following treatment. The median time of AG ≦ 12 mmol/L was approximately 12 h and was the parameter that can identify DKA resolution at a faster rate, i.e., approximately 5, and 6 h faster than the normalization of vpH and HCO3, respectively. Future studies were warranted to use AG ≦12 mmol/L as the endpoint of DKA treatment and check if the treatment course and incidence of HMA could be reduced.

  • Open Access

    Clinical Value of Tocilizumab in Reducing Mortality in Refractory Septic Shock in Children with Hematologic and Non-Hematologic Diseases

    by En-Pei Lee, Jainn-Jim Lin, Shih-Hsiang Chen, Oi-Wa Chan, Ya-Ting Su, Man-Ru Hsiao, Shao-Hsuan Hsia, Han-Ping Wu

    Background: Pediatric sepsis remains the main cause of morbidity and mortality among children. Interleukin (IL)-6 is usually produced after infection, and elevated IL-6 levels may cause multisystemic damage. This study aimed to evaluate the effect of tocilizumab, an IL-6 receptor antibody, on children with septic shock. Methods: We conducted a retrospective cohort study of children diagnosed with septic shock and admitted to the pediatric intensive care unit (PICU) between 2018 and 2024. Tocilizumab was administered within 24 h to patients with high IL-6 levels who developed refractory septic shock. Outcomes, including 28-day mortality, morbidity, length of PICU stay, and shock duration, were analyzed between septic children with different etiologies and differed treatments. Results: Fifty-four children with refractory septic shock were included. Patients treated with tocilizumab (n = 21) showed improved outcomes compared to those without tocilizumab (n = 33), including shorter PICU stays and lower mortality rates (14.2% vs. 54.5%, p = 0.03). Subgroup analysis revealed that in the non-hematologic group, tocilizumab-treated patients had a 0% mortality rate compared to 50% in untreated patients (p = 0.006). In the hematologic group, tocilizumab-treated patients exhibited a 27.2% mortality rate compared to 61.5% in untreated patients (p = 0.09). Trends in IL-6 levels (D1 to D7) were significantly higher in non-survivors compared to survivors and in patients with hematological malignancies compared to those without. No adverse events, including secondary infections or long-term liver impairment, were observed. Conclusions: Tocilizumab appears to mitigate systemic inflammation and improve outcomes in children with refractory septic shock and elevated IL-6 levels. Further prospective studies are warranted to confirm these findings and establish treatment guidelines.


  • Open Access

    Divergent interpretations of child abuse in legal judgments: perspectives from clinicians and forensic experts

    by Ching-Min Tang, Chen-Fang Lou, Shao-Hsuan Hsia, Kuang-Tsung Liang, Wen Chang, Jainn-Jim Lin, Oi-Wa Chan, Kuang-Lin Lin, En-Pei Lee

    Background: Child abuse in Taiwan is a major societal concern that severely affects the well-being of children. Despite the complexity in detecting abuse, reports of child abuse are increasing, evidenced by a rise in cases and heightened awareness. This study utilizes judicial judgments as a lens to understand the varied interpretations of child abuse by clinical and forensic experts and explores the broader epidemiological trends of such abuse within the declining youth population of Taiwan. Methods: We conducted a retrospective study by analyzing official court judgments on child abuse allegations judged from 2008 to 2022 from the online database of Judicial Yuan. Furthermore, the study analyzed demographic factors, injury patterns, and opinions from various experts. Results: The results reveal that severe criminal cases of child abuse predominantly involve biological fathers as the primary offenders and physical abuse as the most common form of maltreatment. Victims are typically aged less than 5 years, which frequently leads to an unfavorable prognosis. Analysis also highlights the TEN-4-FACESp acronym as a highly predictive indicator of child abuse and underscores the prevalence of abusive head trauma (AHT). Moreover, the findings emphasize ongoing disparities in opinions between forensic medical examiners and clinical physicians, especially in AHT cases, which potentially influences judicial decisions. Conclusions: In summary, the study reveals ongoing disagreements between forensic medical examiners and clinical physicians, especially in cases of AHT, which may impact judicial decisions. Promoting consensus through interdisciplinary collaboration and improved communication can aid in revealing the truth in child abuse cases.


  • Open Access

    The Role of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Predicting Complicated Appendicitis in Children

    by Wen-Ya Lin, En-Pei Lee, Chun-Yu Chen, Bei-Cyuan Guo, Mao-Jen Lin, Han-Ping Wu

    Background: Acute appendicitis is a common abdominal emergency observed in emergency departments (ED). Distinguishing between uncomplicated and complicated appendicitis is important in determining a treatment strategy. Serum soluble vascular cell adhesion molecule-1 (VCAM-1) is an inflammatory biomarker. We aimed to determine the role of VCAM-1 in predicting complicated appendicitis in children. Methods: Pediatric patients with suspected appendicitis admitted to the ED were enrolled in this prospective study. Pre-surgical serum VCAM-1 was tested in children with acute appendicitis within 72 h of symptoms (from day 1 to day 3). Serum VCAM-1 levels were further analyzed and compared between patients with and without complicated appendicitis. Results: Among the 226 pediatric appendicitis patients, 70 had uncomplicated appendicitis, 138 had complicated appendicitis, and 18 had normal appendices. The mean serum VCAM-1 levels in patients with perforated appendicitis were higher than in those with simple appendicitis (p < 0.001). On day 1 to day 3, the mean VCAM-1 levels in patients with complicated appendicitis were all significantly higher than in those with uncomplicated appendicitis (all p < 0.001). Conclusion: Serum VCAM-1 levels may be helpful in differentiating uncomplicated and complicated appendicitis in children and could predict appendiceal perforation.


  • Open Access

    Changes in Levels of Serum Cytokines and Chemokines in Perforated Appendicitis in Children

    by Wen-Ya Lin, En-Pei Lee, Chun-Yu Chen, Bei-Cyuan Guo, Mao-Jen Lin, Han-Ping Wu

    Appendicitis is primarily diagnosed based on intraoperative or histopathological findings, and few studies have explored pre-operative markers of a perforated appendix. This study aimed to identify systemic biomarkers to predict pediatric appendicitis at various time points. The study group comprised pediatric patients with clinically suspected appendicitis between 2016 and 2019. Pre-surgical serum interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), intercellular cell-adhesion molecule-1 (ICAM-1), and endothelial selectin (E-selectin) levels were tested from day 1 to day 3 of the disease course. The biomarker values were analyzed and compared between children with normal appendices and appendicitis and those with perforated appendicitis (PA) and non-perforated appendicitis. Among 226 pediatric patients, 106 had non-perforated appendicitis, 102 had PA, and 18 had normal appendices. The levels of all serum proinflammatory biomarkers were elevated in children with acute appendicitis compared with those in children with normal appendices. In addition, the serum IL-6 and TNF-α levels in children with PA were significantly higher, with an elevation in TNF-α levels from days 1 and 2. In addition, serum IL-6 levels increased significantly from days 2 and 3 (both p < 0.05). Serum ICAM-1 and E-selectin levels were elevated in the PA group, with consistently elevated levels within the first three days of admission (all p < 0.05). These results indicate that increased serum levels of proinflammatory biomarkers including IL-6, TNF-α, ICAM-1, and E-selectin could be used as parameters in the prediction and early diagnosis of acute appendicitis, especially in children with PA.


  • Open Access

    Diastolic/systolic blood pressure ratio for predicting febrile children with sepsis and progress to septic shock in the emergency department

    by Chun-Ting Mu, Ying-Jui Lin, Chih-Ho Chen, Shao-Hsuan Hsia, Jainn-Jim Lin, Oi-Wa Chan, Chen-Wei Yen, Chun-Che Chiu, Han-Pi Chang, Ya-Ting Su, et al.

    Given the scarcity of studies analyzing the clinical predictors of pediatric septic cases that would progress to septic shock, this study aimed to determine strong predictors for pediatric emergency department (PED) patients with sepsis at risk for septic shock and mortality. We conducted chart reviews of patients with ≥ 2 age-adjusted quick Sequential Organ Failure Assessment score (qSOFA) criteria to recognize patients with an infectious disease in two tertiary PEDs between January 1, 2021, and April 30, 2022. The age range of included patients was 1 month to 18 years. The primary outcome was development of septic shock within 48 h of PED attendance. The secondary outcome was sepsis-related 28-day mortality. Initial important variables in the PED and hemodynamics with the highest and lowest values during the first 24 h of admission were also analyzed. Overall, 417 patients were admitted because of sepsis and met the eligibility criteria for the study. Forty-nine cases progressed to septic shock within 48 h after admission and 368 were discharged without progression. General demographics, laboratory data, and hemodynamics were analyzed by multivariate analysis. Only the minimum diastolic blood pressure/systolic blood pressure ratio (D/S ratio) during the first 24 h after admission remained as an independent predictor of progression to septic shock and 28-day mortality. The best cutoff values of the D/S ratio for predicting septic shock and 28-day mortality were 0.52 and 0.47, respectively. The D/S ratio is a practical bedside scoring system in the PED and had good discriminative ability in predicting the progression of septic shock and in-hospital mortality in PED patients. Further validation is essential in other settings.